Sign in to view content

The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses

David S. Boyer, MD

Video
Published 2019

David S. Boyer, MD

AMD Neovascular Part II Symposium

Related

The Effect of Intravitreal Afilbercept on Perfusion Status in Patients with Retinal Vascular Disease
Jeffrey S. Heier, MD
Updates from the Field
2016
Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021
Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more